Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted options to purchase 16,950 shares to two non-executive employees as equity inducement awards. The options carry a 10-year term and an exercise price of $21.47, matching the Nasdaq closing price on May 28, 2026.
Key figures
- Term years
- 10
- Exercise price
- 21.47
- Shares granted
- 16950
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.